The mystery patient. In 2007, a person began experiencing severe bouts of debilitating fatigue, low-grade fevers, and pain in her chest, foot, and hand. Soon this spread to her tailbone area and a few other joints in the left side of her body. Since her blood tests and X-rays were normal, her condition was mostly dismissed as stress or unexplained injuries.
Her first rheumatologist diagnosed her with Undifferentiated Connective Tissue Disease (UCTD) – which meant her clinical presentation was not pointing to one, specific disease. While "Undifferentiated Disease" can be treated with first line disease modifying agents, her doctor wanted to watch and wait to see if the disease progressed before treating it. As a result, the pain had spread to two dozen locations on both sides of her body. She was sleeping sixteen hours a day and had been running a fever for more than four weeks without relief. After seeking out the help of a new rheumatologist, she was diagnosed with sero-negative Rheumatoid Arthritis (RA), which meant all of her blood work and x-rays were normal, but she had enough clinical features to meet the diagnostic criteria for RA - even though many of her symptoms were not typical of the disease.
The new rheumatologist prescribed her first line disease modifying agents and within days her fever broke, she was back to a normal sleep schedule, and the pain had diminished significantly. However, due to the delay in treatment, an magnetic resonance image (MRI) of the left wrist showed inflammatory damage.
This persons' journey to diagnosis is not unique. But it did inspire her to do something to raise awareness about these very misunderstood diseases. Little did she know it was about to snowball into something much bigger.
A voice determined to impact change.
In 2009, after her diagnosis with Rheumatoid Arthritis, Tiffany Westrich-Robertson - who at the time was working as a Vice President of Business Development and Project Management of an architectural firm, as well as public speaker and college educator - decided to create an awareness movement, centered around a trendy "buckle cuff" bracelet. The "Buckle Me Up!" Movement, as it was called, aimed to re-brand this type of arthritis as a part of a more complex disease that typically has young onset.
Each bracelet came with a message that explained the meaning behind the pattern of beads in the design: "The three silver and black beads represent all people in a community working together for impact (red bead) to bring change (last gray bead)."
Many stories help "connect the dots". The Movement was featured on a popular blog, and additionally was launched at the same time social media popularized. As a result, in just a few months orders came in from all over the world - over 30 states in the US, Canada, Ireland, Scotland, Australia, New Zealand, UK, Turkey, Japan, and several other countries. Instead of simply designing and mailing each piece, Tiffany personally emailed each person who placed an order, thanking them, telling them her story, and asking them theirs. Most people responded with their stories, but much to her surprise while they were similar to hers, not everyone was diagnosed with RA. Some had Psoriatic Arthritis or Lupus or Ankylosing Spondylitis or Sjogren's Syndrome or Still's Disease or Juvenile Arthritis. Others had originally been diagnosed with one of these diseases, yet been re-diagnosed with another. Yet some had dual, even triple diagnoses, while many were struggling to get just one diagnosis.
The conversations moved from email to online, as community Facebook groups and blogs continued to form at rapid speed. For the first time, people affected by these diseases were able to communicate with one other outside of their immediate communities, and it was exciting! It was also the first time we were able to learn more about our journeys, our struggles, our similarities, our experiences - we were no longer alone.
It was also the first time we realized that regardless of the diagnosis, we all had were experiencing similar challenges. This is when it became clear of the need for an international nonprofit that focused only on the small group of autoimmune and autoinflammatory diseases that presented with arthritis as a major clinical component early in onset.
Communication. Through online conversations via social media, we identified the following core issues that justified the need to become a nonprofit:
The results of these conversations have since become the heart and soul of our current day business model and are at the core of our mission and vision. Then, through continued conversations with our community, we identify the most pressing immediate issues and they become our annual initiatives to solve.
Leadership. In addition to Tiffany, Tami Caskey Brown and Amanda John were original co-founders, joined by Kelly Conway in 2013, when the organization expanded our platform and programs. All co-founders have strong backgrounds in business or education and more recently have been getting involved in research. Since becoming a nonprofit, several of our volunteers who lead projects have professional experience, which enables us to successfully serve as a communicative bridge between various stakeholders and a global pool of patients and their supporters.
In 2012, our first full year as an organization, we won "Best Ensemble Cast" for our work in the awareness and wellness education arena. Since then our nonprofit and active volunteer representatives have collectively been nominated for nearly 50 awards since inception. Our passion and commitment to making a difference is evident in all we do. A few of the highlights include:
We have been consistently recognized for our strong team approach. Our first full year as a nonprofit we won this WEGO Health Award. Since then, we have been nominated for it each year and in 2017 we were a finalist. Then in 2022 we won...again!
Our A Community Team (ACT) project tested patients in research leadership roles with professionals as advisors and enabled a global pool of patients to have a voice in drug development, regardless of location, prior advocacy experience, or disease limitations. In 2018, we were finalists for our Preparing Patients for Precision Medicine Trials, which resulted in a Patient-Led Shared-Decision Making Clinical Trial Guide.
International Foundation for AiArthritis
6605 Nottingham Ave.
St. Louis, MO 63109-2661
Tax ID: 27-1214308
Copyright 2024. All rights reserved. Information on this site is intended for informational purposes only Our foundation does not engage in the practice of medicine. Please consult a physician to obtain personal healthcare and treatment options. 501(c) 3 Nonprofit Tax ID: 27-1214308.